46, Main Rd, Cottonpet, Bangalore, Karnakata
+91 41223629
At Matrix Laboratories, we aim to be a chemistry solutions provider for your small molecule Drug Development needs. We give each project individual attention because every project presents its own challenges and opportunities. We maintain a high level of confidentiality, solve difficult problems and are equipped to handle most aspects of Chemical Development and Manufacturing.
Our chemists have extensive experience scaling processes from the lab to the kilo-lab, pilot-scale, and commercial scale.
When scaling up a process, we do safety testing and hazard analysis to verify that it is safe.
We may transfer technology to a customer’s location, as well as produce Qualification and Validation batches for filing purposes. However, we would prefer that the customer use our modern facilities, which have been approved by the US-FDA, MCA, and TGA.
Hydrogenation / high pressure reactions upto 20kg/sq.cm
(250 ltrs to 2000 ltrs)
5 high vacuum distillation units
Reaction temperatures from -60 ºC to 270 ºC
Separate cGMP pilot plant for bio batches
Dedicated NaH handling facility
100 kg/hr air jetOrdinary pharmacies can fill hundreds of prescriptions every day. This demand can put a lot of pressure on pharmacists and their staff to maintain adequate staff levels throughout the day while still serving customers without allowing long lines. In addition,…
Biogaran, a French pharmaceutical business specialising in generic medications and a subsidiary of the Servier Group, has announced the start of operations in the Ivory Coast. Biogaran has started offering 14 medicines from its over 800 product line since January….
BEGINNING One of the most significant pharmaceutical manufacturing and control functions is the pharmaceutical quality control laboratory. The quality control laboratory and product testing are covered by a large component of the CGMP requirements (21 CFR 211). Bulk medications have…
In a landscape where industries are continually evolving, the intersection of healthcare and casino licensing presents a unique narrative. While seemingly disparate, these two realms share common ground in the importance of regulatory frameworks and ethical considerations. A notable addition to this conversation is the emerging trend of “casino utan konto” (casinos without an account), challenging traditional casino registration processes. This avant-garde approach, while unrelated to healthcare on the surface, introduces a new layer to the discussion around licensing, as both industries adapt to innovative methodologies to enhance user experiences and streamline access. In this exploration, we delve into the intriguing dynamics where health and entertainment meet within the context of licensing, incorporating the progressive shift in casino operations exemplified by “casino utan konto.”